Wang, H., Zhang, L., Shi, X., Zhang, X., & Si, X. (2019). Successful treatment with osimertinib and its subsequent resistance mechanism in a patient with non-small-cell lung cancer harboring acquired EGFR T790M mutation after recovery from AC0010-induced interstitial lung disease. Onco Targets Ther.
シカゴスタイル引用形Wang, Hanping, Li Zhang, Xiaohua Shi, Xiaotong Zhang, , Xiaoyan Si. "Successful Treatment With Osimertinib and Its Subsequent Resistance Mechanism in a Patient With Non-small-cell Lung Cancer Harboring Acquired EGFR T790M Mutation After Recovery From AC0010-induced Interstitial Lung Disease." Onco Targets Ther 2019.
MLA引用形式Wang, Hanping, et al. "Successful Treatment With Osimertinib and Its Subsequent Resistance Mechanism in a Patient With Non-small-cell Lung Cancer Harboring Acquired EGFR T790M Mutation After Recovery From AC0010-induced Interstitial Lung Disease." Onco Targets Ther 2019.